Back to Best of AC17 Session - Updates in the Treatment of Pancreatic Cancer - On-Demand
Best of AC17 Session - Updates in the Treatment of Pancreatic Cancer - On-Demand

Best of AC17 Session - Updates in the Treatment of Pancreatic Cancer - On-Demand

Over the past several years new chemotherapy regimens have demonstrated improvement in survival for patients with pancreatic cancer, however, with varying toxicity profiles. This session will review recent clinical data for the treatment of pancreatic cancer and provide guidance on selecting appropriate treatment plans for patients with metastatic disease.

 

Content Area: Patient Management & Therapeutics

Product Details

Updates in the Treatment of Pancreatic Cancer

 

Speaker: Andrea Landgraf Oholendt, PharmD BCOP

 

Learning Objectives:

1.      Summarize recent advancements in chemotherapy for the treatment of pancreatic cancer.

2.      Compare the benefits and limitations of chemotherapy regimens for the treatment of metastatic pancreatic cancer.

3.      Select a chemotherapy treatment plan for a patient with metastatic pancreatic cancer.

 

  • List Price: $35.00 USD
  • Member Price: $25.00 USD
Join and Save!
Log into see if you qualify for a lower price.
HOPA members save $10.00 USD or more!
Become a member